Schwartz Michael, Patel Manish, Kazzi Ziad, Morgan Brent
Georgia Poison Center, Emory University School of Medicine, Atlanta, GA 30333, USA.
J Med Toxicol. 2008 Sep;4(3):173-9. doi: 10.1007/BF03161197.
Amantadine hydrochloride is an antiviral medication used as therapy for parkinsonism and as a cognitive enhancer. We report 2 cases of massive, acute ingestion of amantadine hydrochloride confirmed with serial serum levels.
A 47-year-old woman presented to the emergency department (ED) 30 minutes after ingesting 10 g of amantadine (150 mg/kg) by her report. Initial ECG revealed a sinus rhythm with rate of 93 bpm, and a QRS of 84 msec. While in the ED, the patient sustained a pulseless cardiac arrest and the monitor revealed ventricular tachycardia. She was successfully defibrillated. Postdefibrillation ECG showed a sinus rhythm (rate = 82 bpm), QRS of 236 msec, and QTc of 567 msec. The serum potassium was 1.0 mEq/L (1.0 mmol/L). The patient was given 300 ml (300 cc) 3% sodium chloride IV over 10 minutes. Ten minutes after completion of the hypertonic saline infusion, the patient's ECG abnormalities resolved and the QRS was 88 msec. Her potassium was repleted over the next 11 hours postpresentation, and she also received an IV bolus of 4 g of magnesium sulfate immediately after the cardiac arrest. No further hypotension, dysrhythmia, conduction delay, or ectopy was noted during the patient's hospital stay. The second case involved a 33-year-old female patient who presented 1 hour after ingesting 100 tablets of amantadine hydrochloride (100 mg/tab). Initial ECG revealed sinus tachycardia with a QRS of 113 msec, an R wave in lead aVR of 4-5 mm and a QTc of 526 msec. Her serum potassium was 3.0 mEq/L (3.0 mmol/L), her serum calcium was 9.4 mg/dl (2.35 mmol/L), and serum magnesium was 2.1 mg/dl (0.86 mmol/L) on labs drawn at initial presentation. The patient was intubated for airway protection, and her potassium was repleted and corrected over the next 9 hours. Her ECG abnormalities improved 8 hours after initial presentation and normalized at approximately 14 hours postingestion. The patient was discharged home 11 days after her ingestion.
Acute amantadine toxicity manifests with life-threatening cardiotoxicity. Concurrent, often profound, hypokalemia may complicate the administration of sodium bicarbonate in the management of cardiac dysrhythmias.
盐酸金刚烷胺是一种抗病毒药物,用作帕金森病的治疗药物和认知增强剂。我们报告2例经连续血清浓度证实的大量急性摄入盐酸金刚烷胺的病例。
一名47岁女性据其自述在摄入10克金刚烷胺(150毫克/千克)后30分钟就诊于急诊科(ED)。初始心电图显示窦性心律,心率93次/分,QRS波时限84毫秒。在急诊科时,患者发生无脉性心脏骤停,监护仪显示室性心动过速。她成功接受了除颤。除颤后心电图显示窦性心律(心率 = 82次/分),QRS波时限236毫秒,QTc间期567毫秒。血清钾为1.0毫当量/升(1.0毫摩尔/升)。患者在10分钟内静脉输注了300毫升(300立方厘米)3%氯化钠溶液。高渗盐水输注结束10分钟后,患者的心电图异常消失,QRS波时限为88毫秒。在就诊后的接下来11小时内她的血钾得到补充,并且在心脏骤停后立即静脉推注了4克硫酸镁。在患者住院期间未再发现进一步的低血压、心律失常、传导延迟或异位心律。第二例涉及一名33岁女性患者,她在摄入100片盐酸金刚烷胺(每片100毫克)后1小时就诊。初始心电图显示窦性心动过速,QRS波时限113毫秒,aVR导联R波4 - 5毫米,QTc间期526毫秒。初次就诊时实验室检查显示她的血清钾为3.0毫当量/升(3.0毫摩尔/升),血清钙为9.4毫克/分升(2.35毫摩尔/升),血清镁为2.1毫克/分升(0.86毫摩尔/升)。为保护气道对患者进行了气管插管,在接下来的9小时内她的血钾得到补充和纠正。初次就诊8小时后她的心电图异常有所改善,摄入后约14小时恢复正常。患者在摄入后11天出院回家。
急性金刚烷胺中毒表现为危及生命的心脏毒性。在治疗心律失常时,同时存在的、往往较为严重的低钾血症可能使碳酸氢钠的使用复杂化。